Version française

Patents

For any further information regarding patents presented on this site, please contact Valérie Bourgine (01 46 54 76 26) or Romain Marlange (01 46 54 91 99).

Patents deposited in 2010

  • Process of simultaneous extraction for the input function and pharmacokinetic parameters of an active molecule. Registration number : FR 10 51738
  • Aptamers against annexin 2 and their usage. Registration number: FR 10 04412
  • Aptamers against the LAR protein and their usage. Registration number: FR 10 60619

Patents deposited in 2009

  • Method to exite nuclear spins with different flip angles depending on their resonance frequency. Registration number: 2009/005066
  • Tumor segmentation and detection in PET. Registration number: 0951289
  • Prediction device, use, information storage support. Registration number: 0951556
  • Multimeric polypeptides of HLA-G alpha 3 domain and pharmaceutical uses theof. Registration number : 2009/006491
  • Nuclear magnetic resonance detection process by J coupling suppression. Registration number: FR 0904424

Patents deposited in 2008

  • Specific aptamers generated for suppression of cell migration and invasion by cancer cells, methods of selection for such aptamers and their usage. Registration number: EP 08290022.6
  • Preparation process of labeling a purine derivative and its usage. Registration number: FR 0850014
  • Process for estimating a tracer concentration into a set of tissue structures, corresponding information support and device. Registration number: FR 0857251
  • Single use preparation kit for radioactive products in medical imaging. Registration number: FR 0857206
  • HLA-G polypeptides and pharmaceutical uses thereof. Registration number: EP 08168677.6
  • HLA-G proteins and pharmaceutical uses thereof. Registration number: EP 08168675.0
  • Usage of a soluble form of HLA-G in the treatment of abnormal B lymphocyte proliferation. Registration number: FR 08 04404
  • Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels. Registration number: EP 08291013.4